|Doc, I've Got a Virus!|
In the News
THE U.S. Food and Drug Administration (FDA) has issued a black box warning for the DAAs used in the treatment of chronic hepatitis C virus. There have been reports in the literature and to the FDA of hepatitis B virus reactivation and several cases of fulminant hepatitis B in patients who are co-infected with hepatitis C virus and hepatitis B virus who begin anti-HCV DAA treatment. U.S. hepatitis C guidelines have been updated to include recommendations for hepatitis B virus testing prior initiation of DAA treatment and suppressive therapy for hepatitis B virus during DAA treatment for individuals who meet HBV treatment criteria.
As the influenza season in South America is winding down, the World Health Organization is recommending that a new clade 6B influenza A H1N1 virus A/Michigan/45/2015 (H1N1) replace A/California/7/2009 (H1N1) pdm09-like virus
Zika Virus Resource Center
New Zika Virus Special Travel Considerations for 11 Southeast Asian Countries [Brunei, Burma (Myanmar), Cambodia, Indonesia, Laos, Malaysia, Maldives, Philippines, Thailand, Timor-Leste (East Timor), Vietnam] Posted by CDC
CDC Updates Guidance for Travel and Testing of Pregnant Women and Women of Reproductive Age for Zika Virus Infection Related to the Ongoing Investigation of Local Mosquito-borne Zika Virus Transmission in Miami-Dade County, Florida (HAN-00396)